SIRNAOMICS logo — company profile

SIRNAOMICS

Founded 2007 United States Germantown, United States 37 employees Grant Total: $275.00M Biopharma, Biotechnology +2

General Information

Company Name SIRNAOMICS
Founded Year 2007
Location United States Germantown, United States
Founders / Decision Makers
Team member
Employees 37
Industries Biopharma, Biotechnology, Medical Devices +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with SIRNAOMICS. To contact SIRNAOMICS, visit sirnaomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About SIRNAOMICS

Sirnaomics is a prominent RNA therapeutics biopharmaceutical company that was established in 2007. The company is dedicated to discovering and developing innovative drugs for indications with substantial medical needs and significant market opportunities. Sirnaomics has made remarkable progress, with product candidates in both preclinical and clinical stages. One of its core products, STP705, has achieved positive Phase IIa clinical outcomes in oncology, making Sirnaomics the first clinical-stage RNA therapeutics company to have a strong presence in both China and the United States. The company's unique positioning offers a strategic advantage in catering to diverse markets. With a focus on biopharma, biotechnology, and pharmaceutical industries, Sirnaomics aligns itself with cutting-edge developments in the life sciences sector. The recent HKD8.00M grant investment received on 17 May 2023 from the Hong Kong Science and Technology Parks Corporation further consolidates the company's growth trajectory. Sirnaomics' pioneering achievements in RNA therapeutics, combined with its dual presence in key global markets, position it as an attractive prospect for venture capitalists seeking investment opportunities in the biopharmaceutical sector. With a commitment to addressing unmet medical needs and a strong pipeline of product candidates, Sirnaomics presents an intriguing opportunity for venture capital firms looking to invest in innovative and disruptive biopharmaceutical companies. Learn more at www.sirnaomics.com.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant HKD8.00M 1
Hong Kong Science and Technology Parks Corporation
17 May 2023
Series E $105.00M 2
Rotating Boulder Fund, Founder H Fund
01 Jul 2021
Series D $105.00M 7
Alpha Win Capital, HongTao Capital +5
23 Oct 2020
Series C $22.00M 4
Rolling Boulder Investment, Rich Yield Capital +2
29 Apr 2019
Series C $25.00M 4
Sangel Capital, Qianhai Shenghui Investment +2
06 Jun 2018
Series B $10.00M 1
Value Measured Investment Limited
28 Apr 2016
Venture Round Undisclosed -
11 Nov 2015
Venture Round Undisclosed 1
Maryland Department of Business and Economic Development
26 Dec 2007

SIRNAOMICS Alternatives & Competitors

View All Alternatives
SIRNAOMICS vs

Contributing to the Health and Happiness of Mankind with RNAi Technology

Post-IPO Equity
38 employees
Biotechnology, Pharmaceutical
SIRNAOMICS vs

Developing novel mRNA-based therapeutics

Seed
11 employees
Biotechnology, Health Care
SIRNAOMICS vs

Our vision is to provide effective and safe RNA therapeutics to patients who suffer from intractable...

Series C
94 employees
Biotechnology, Health Care

FAQ About SIRNAOMICS

Sirnaomics is an RNA therapeutics biopharmaceutical company that focuses on the discovery and development of innovative drugs for indications with unmet medical needs and large market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics company to have a strong presence in both Asi...
SIRNAOMICS was founded in 2007.
SIRNAOMICS is headquartered in Germantown, United States.
SIRNAOMICS operates in Biopharma, Biotechnology, Medical Devices and Pharmaceutical.
SIRNAOMICS has approximately 37 employees.
SIRNAOMICS has completed 8 funding rounds, raising a total of $275.00M. The latest funding stage is Grant.
Top alternatives and competitors to SIRNAOMICS include OliX Pharmaceuticals, Inc., Pantherna Therapeutics GmbH, ADARx Pharmaceuticals Inc., Stemirna Therapeutics, Prelude Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SIRNAOMICS and OliX Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SIRNAOMICS, https://bouncewatch.com/company/sirnaomics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes